Leadership Overview
Certara has 10 executives leading key functions including strategy, technology, finance, marketing, human resources, data sciences, drug development, and interim development.
Driven by innovation, Certara provides essential services and software across the entire drug development lifecycle, from initial discovery through to market access, impacting global health outcomes.
Driven by innovation, Certara provides essential services and software across the entire drug development lifecycle, from initial discovery through to market access, impacting global health outcomes.
Leadership Roles at Certara
Jon Resnick - Chief Executive Officer
Jon Resnick, the Chief Executive Officer at Certara, directs the company's overarching strategy and operational execution. Resnick guides Certara's mission to accelerate the development of life-changing medicines by providing critical services and software solutions. Overseeing global operations, the Chief Executive Officer ensures alignment with corporate objectives and market demands. This leadership role involves driving innovation and fostering a culture of scientific excellence across all divisions. By optimizing resource allocation and strategic partnerships, Jon Resnick directly impacts the company's growth and its ability to serve clients worldwide. Ultimately, Resnick secures Certara's position as a leader in the drug development ecosystem.

Kelly Brooks - Chief Financial Officer
Kelly Brooks, the Chief Financial Officer at Certara, manages the company's financial strategy and operations. Brooks oversees all fiscal activities, including budgeting, forecasting, and financial reporting, ensuring fiscal health and strategic resource allocation. Directing financial planning, the Chief Financial Officer supports Certara's growth objectives and operational efficiency across its global locations. This critical role involves managing investor relations and capital management to fund expansion and innovation. By providing financial insights and controls, Kelly Brooks directly impacts Certara's profitability and long-term sustainability. Ultimately, Brooks safeguards the company's financial integrity and drives value for stakeholders.
Martin Snyder - President, Certara Data Sciences
Martin Snyder, the President of Certara Data Sciences at Certara, directs the company's advanced data analytics and modeling capabilities. Snyder leads the teams responsible for generating actionable insights from complex biological and clinical data to accelerate drug development. Overseeing data science operations, the President, Certara Data Sciences ensures the delivery of cutting-edge solutions that inform critical decision-making for clients. This leadership position involves leveraging AI and machine learning to solve challenging problems in drug discovery and patient outcomes. By driving innovation in data analytics, Martin Snyder directly enhances Certara's ability to provide predictive and prescriptive insights. Ultimately, Snyder empowers clients with data-driven strategies to bring therapies to market faster.

Paul Gallagher - President & Founder
Paul Gallagher, the President & Founder at Certara, provides foundational leadership and strategic vision for the company. Gallagher established Certara with a commitment to advancing drug development through innovative services and software. Guiding the company's long-term direction, the President & Founder ensures adherence to the core mission of accelerating therapeutic access. This pivotal role involves fostering key relationships and championing the company's pioneering spirit. By drawing on deep industry knowledge, Paul Gallagher directly influences Certara's strategic growth and market impact. Ultimately, Gallagher continues to shape Certara's legacy as a transformative force in the life sciences sector.
Adrian McKemey - President, Certara Drug Development Solutions
Adrian McKemey, the President of Certara Drug Development Solutions at Certara, leads the comprehensive suite of services supporting the entire drug development pipeline. McKemey oversees the integration of scientific expertise and technological platforms to optimize client projects from discovery through regulatory submission. Directing drug development operations, the President, Certara Drug Development Solutions ensures the highest standards of scientific rigor and project execution across global teams. This executive function involves managing complex project portfolios and fostering collaborative client partnerships. By enhancing service delivery and operational efficiency, Adrian McKemey directly contributes to Certara's reputation for excellence and client success. Ultimately, McKemey facilitates the efficient progression of novel therapies to patients.

Chris Bouton - Chief Technology Officer
Chris Bouton, the Chief Technology Officer at Certara, architects the company's technological infrastructure and innovation roadmap. Bouton drives the development and implementation of advanced software solutions that enhance drug discovery and development processes. Overseeing all technology functions, the Chief Technology Officer ensures robust, scalable, and secure platforms for clients globally. This leadership position involves evaluating emerging technologies and integrating them to maintain Certara's competitive edge. By leading digital transformation initiatives, Chris Bouton directly impacts the efficiency and effectiveness of Certara's service offerings. Ultimately, Bouton champions technological advancements that accelerate therapeutic breakthroughs.

Sheila Rocchio - Chief Marketing Officer
Sheila Rocchio, the Chief Marketing Officer at Certara, shapes the company's brand strategy and market positioning. Rocchio leads initiatives to communicate Certara's value proposition to the pharmaceutical and biotechnology industries worldwide. Driving market engagement, the Chief Marketing Officer ensures consistent messaging and brand awareness across all communication channels. This executive function involves understanding market dynamics and client needs to inform product development and service offerings. By developing targeted marketing campaigns, Sheila Rocchio directly enhances Certara's market reach and client acquisition efforts. Ultimately, Rocchio strengthens Certara's reputation as a trusted partner in drug development.

Rona Anhalt - Chief Human Resources Officer
Rona Anhalt, the Chief Human Resources Officer at Certara, leads the company's talent management and organizational development strategies. Anhalt oversees all human resources functions, ensuring Certara attracts, develops, and retains a high-performing global workforce. Championing employee engagement, the Chief Human Resources Officer cultivates a positive and productive work environment that supports Certara's mission. This strategic role involves designing HR policies and programs that align with business objectives and foster a culture of collaboration and innovation. By managing talent acquisition and development, Rona Anhalt directly contributes to Certara's operational capacity and long-term success. Ultimately, Anhalt ensures Certara has the skilled personnel necessary to achieve its ambitious goals.

John Gallagher - Interim Chief Development Officer
John Gallagher, the Interim Chief Development Officer at Certara, provides critical leadership during a transitional phase for the company's development functions. Gallagher oversees key development initiatives, ensuring continuity and progress in advancing Certara's service offerings. Managing development projects, the Interim Chief Development Officer maintains momentum and strategic focus on critical programs. This temporary leadership role involves assessing current development strategies and identifying areas for immediate improvement. By ensuring operational stability, John Gallagher directly supports Certara's ongoing commitment to innovation and client service. Ultimately, Gallagher facilitates a smooth transition and upholds the company's development objectives.
Cynthia Collins - Member of the Board
Cynthia Collins, a Member of the Board at Certara, provides strategic oversight and governance. Collins contributes extensive industry experience to guide Certara's long-term vision and corporate direction. Serving on the board, the Member of the Board ensures accountability and promotes sustainable growth. This governance role involves advising executive leadership on critical business decisions and market opportunities. By offering seasoned perspectives, Cynthia Collins directly influences Certara's strategic planning and risk management frameworks. Ultimately, Collins supports the board's fiduciary duty to stakeholders and the company's mission.
Explore Leadership Teams in Business Services
A wholly-owned company of the Malaysian Government under the Minister of Finance Incorporated, SIRIM Berhad is a premier Research and Technology organisation providing timely and focused research. SIRIM Berhad is also the champion of Quality and has gained international recognition in Standards and Conformity Assessment, underlying its mission "as a Leader in Quality and Technology Development.
Company Leadership DN
NM
SM
The Association of Universities for Research in Astronomy operates as a nonprofit consortium of academic institutions and international partners dedicated to advancing observational astronomy through strategic management of major research facilities. The organization critical bridge between the scientific community and federal funding agencies, overseeing the operations of world-class astronomical research centers that enable transformative discoveries about the universe. Founded as a collaborative framework for universities to pool resources and expertise, the association has developed sophisticated operational models for managing complex astronomical observatories and research infrastructure. This institutional structure allows member universities to maintain scientific independence while benefiting from shared administrative capabilities, technical expertise, and access to cutting-edge instrumentation. The organization's governance model reflects a commitment to fostering collaborative research across institutional boundaries. AURA Astronomy directs operations of multiple astronomical research centers that serve the broader scientific community through telescope access, data management, and research support services. These facilities enable astronomers to conduct observations across multiple wavelengths and scales, from studying distant galaxies to examining stellar phenomena.
Company Leadership MM
CF

LC
Embrapa (Brazilian Agricultural Research Corporation) is a Brazilian public research institution headquartered in Brasilia, Brazil. Founded in 1973 and linked to the Ministry of Agriculture, Embrapa conducts agricultural research and development to improve productivity, sustainability, and competitiveness of Brazilian agriculture. The organization operates a network of research centers across Brazil.
Company Leadership FO
SM
RC
Founded in 1923, Wood Mackenzie, also known as WoodMac, is a global energy, chemicals, renewables, metals & mining research and consultancy group, with an international reputation for supplying comprehensive data, written analysis & consultancy advice. Wood Mackenzie is headquartered in Edinburgh, United Kingdom
Company Leadership MV
SP
RN
